Posts by month
November 2020
Roundtable ‘grasps nettle’ on European cancer inequalities
Improving treatment of older patients and closing the East−West divide were the focus of a Community 365 Roundtable on Inequalities organised by the European Cancer Organisation on the 14th October. This event was the first of a series of Community…
Gut microbiome positively influences abiraterone response in prostate cancer
Abiraterone acetate (AA), an agent used in castrate-resistant prostate cancer, promotes a shift towards health-associated, anti-inflammatory gut commensal bacteria, finds a study in Nature Communications. “These findings clearly demonstrate that the gut microbiome is playing a role in treatment response,”…
Cervical cancer: the SENTIX trial
Interview with David Cibula, MD, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Q. Your recent paper in the European Journal of Cancer (EJC 137 (2020) 69-80) on the SENTIX…
Stella Kyriakides: EU Commissioner for Health
When Stella Kyriakides took on the post of EU Health Commissioner in September 2019, Europe’s cancer community knew they could trust her to fight their cause. Within months she was launching a public consultation on Europe’s Beating Cancer Plan. Then…